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Background: The burden of bloodstream infections is insufficiently studied in children in Africa and many healthcare
facilities lack the capacity to identify invasive disease. Often studies have been limited to febrile patients or patients
admitted to hospital.
Methods: Blood cultures and malaria diagnostics was performed on 372 consecutive children presenting with
tachycardia and/or fever to a referral paediatric emergency department in Bissau, Guinea-Bissau. Bacterial species
detection, antimicrobial susceptibility testing and molecular typing were performed. The capacity of clinical parameters
to identify bacteraemia was evaluated.
Results: The prevalence of bloodstream infection was 12% (46/372) and in 46% (21/46) of the infections the child was
non-febrile at presentation to the hospital. The predictive value for bacteraemia was poor for all assessed clinical
parameters. Staphylococcus aureus accounted for 54% (26/48) of the isolates followed by non-typhoidal Salmonella,
10% (5/48), Streptococcus pneumoniae, 8% (4/48), and Salmonella Typhi, 6% (3/48). Among S. aureus there was a large
diversity of spa types and 38% produced Pantone-Valentine leukocidin. Antibiotic resistance was low, however two out
of three Klebsiella pneumoniae isolates produced extended-spectrum beta-lactamases. Malaria was laboratory confirmed
in only 5% of the children but 64% (237/372) received a clinical malaria diagnosis.
Conclusions: Bacteraemia was common irrespective of the presence of fever among children presenting to the
hospital. The high prevalence of Staphylococcus aureus may be due to contamination. There is an imminent need to
improve microbiological diagnostic facilities and to identify algorithms that can identify children at risk of bloodstream
infections in Africa.
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Molecular epidemiologyBackground
The burden of disease attributable to bloodstream infec-
tions (BSIs) is insufficiently studied in Africa where few
healthcare facilities have the capacity to identify invasive
diseases. BSIs are increasingly recognized as an important
cause of hospitalisation and mortality in the region, and
studies indicate that the prevalence of and mortality in
bacteraemia parallels or exceeds that of malaria [1-4].* Correspondence: joakim.isendahl@ki.se
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unless otherwise stated.Due to symptom overlap bacteraemia is frequently mis-
classified as malaria and malaria is often over-diagnosed
[3,5-7]. Malaria may occur concomitantly with and has
been indicated as a risk factor for bacteraemia [3,8,9]. Yet,
the World Health Organization’s (WHO) guidelines for
management of acute paediatric illness primarily focus on
malaria and do not include BSIs in the diagnostic algorithm
for fever in the absence of general danger signs [10,11].
It would be valuable to identify children at risk of bacter-
aemia, where blood cultures should be performed. How-
ever, studies have demonstrated poor predictive values of
clinical signs to detect bacteraemia [2,4]. In a study from
Kenya where blood cultures were performed on all childrenl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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of fever to detect BSIs was only 73% [2].
There are reported differences in the aetiology of BSIs
between African regions that may limit the effectiveness
of treatment recommendations and immunization pro-
grammes [1,12-16] and antibiotic resistance is an increas-
ingly recognized problem [3,4,17]. There is to our know
ledge no study that have investigated the prevalence of
bacterial blood stream infections in Guinea-Bissau and
many previous studies of bacteraemia in Africa have been
limited to febrile or hospitalized patients, which may limit
the generalizability of the findings [12-15].
The objective of this study was to investigate the preva-
lence, species distribution and antibiotic susceptibility of
BSIs in consecutive children presenting with systemic
infection signs to a paediatric emergency department in
Guinea-Bissau. We also aimed to investigate the predictive
capacity of clinical parameters to identify BSIs.
Materials
Study setting
The study was carried out between June and September
2010 at the paediatric emergency department of Simão
Mendes, the national hospital in Guinea-Bissau. The de-
partment is the national referral centre for paediatrics, yet
more than 90% of the enrolled children resided in or near
the capital Bissau. The population of the capital is 423000
and 41% of the population is under age 15 [18]. The rainy
season lasts from May-November. The community mal-
aria prevalence in children was low in 2003 and 2008, 3%
and 4% respectively [6,19]. The adult HIV prevalence in
2006 was 4.6% for HIV-1 and 4.4% for HIV-2 [16]. Vacci-
nations against tuberculosis, polio, diphtheria, tetanus and
pertussis have been performed since the 1980s (coverage
70-90% in 2009) while yellow fever, hepatitis B and
Haemophilus influenzae type b vaccinations started in
2008–09 [20]. Blood cultures were not part of routine
management at the paediatric department during the time
of the study. Microscopic examination of blood for mal-
aria was routinely available at the hospital at an extra fee.
Study population
A pre-defined study size of 400 children was judged to be
sufficient to provide an estimate of the burden of antibiotic
resistance. The study was stopped when the pre-defined
number of study participants was included. All children
presenting to the emergency department between 9 am
and 5 pm on weekdays were assessed for enrolment. The
inclusion criteria were fever (axillary temperature ≥38°C)
and/or tachycardia [<1 year ≥160 beats per minute (bpm),
1–5 years ≥120 bpm, measured with a pulse oximeter].
These criteria were selected since they together would have
a high sensitivity to detect BSIs in children [2]. Two re-
search nurses recorded clinical parameters, symptoms andclinical management. Inpatient mortality was retrieved
from hospital registers. The exact number of children
eligible for enrolment is not known, however the research
nurses have declared that very few guardians declined
participation for their child.
Sampling and laboratory methods
Venous blood samples were drawn before the initiation of
antibiotic treatment. The research nurses retrieved 3–4 ml
(1 ml in neonates) of blood after thoroughly cleansing the
skin with 70% ethanol. The samples were inserted into Bac-
tALERT Paediatric-fan blood culture bottles (bioMérieux,
Marcy-l’Etoile, France), stored in ambient temperature
overnight and then transported for incubation and culture
at the National Public Health Laboratory. After 24 and 28
hours of incubation, the samples were cultured on in-house
blood and chocolate agars and on a cysteine, lactose
and electrolyte deficient (CLED) agar. Unique colony
morphologies were frozen in −20°C in a freezing
medium for sensitive bacteria used by and manufactured
at the Department of Clinical Microbiology at Karolinska
University Hospital in Stockholm, Sweden. At the end of
the study period all samples were transported on dry ice
to the Department of Clinical Microbiology at Karolinska
University Hospital.
In Sweden, phenotypic species identification was per-
formed with the VITEK2 system (bioMérieux). Antibiotic
susceptibility patterns were established with the VITEK2
system, E-test (bioMérieux) and the disk diffusion method
(Oxoid AB, Malmö, Sweden), using the standardised bac-
teriological methods, minimum inhibitory concentrations
and breakpoints advised by the European Committee on
Antibiotic Susceptibility Testing [21]. Blood cultures
growing coagulase-negative Staphylococci, Sphingomonas,
Bacillus, Streptococcus viridans, and Acinetobacter not
confirmed as Acinetobacter baumanii were considered as
probable contaminants and reported as negative in the
analysis [4].
Acinetobacter isolates were subjected to the matrix-
assisted laser desorption/ionization time-of-flight assay
for species determination. Isolates producing extended-
spectrum β-lactamases (ESBLs) were analysed with
regard to resistance-encoding gene type with the Check-
MDR multiplex PCR (Check-Points, Wageningen, The
Netherlands). Streptococcus pneumoniae serotyping was
performed by gel diffusion or capsular reaction testing
[22]. Staphylococcus aureus isolates were characterized
with regard to Protein A (spa) type and presence of
Pantone-Valentine leukocidin (PVL) using an in-house
method at the Swedish Institute for Communicable
Disease Control.
Thin and thick smears for malaria microscopy were
collected at admission to the hospital and subsequently
read by an expert in Sweden. Droplets of blood were
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using the Chelex boiling method [23]. A nested PCR that
targets the cytb gene (cytb-PCR), common to all Plasmo-
dium species, was performed followed by a restriction
fragment length polymorphism assay to determine para-
site species [24,25]. Parasite densities were measured
with an 18Sq-PCR assay [26]. Children aged 1–5 years
with a positive blood smear and/or cytb-PCR in conjunc-
tion with a parasite density ≥2500p/μl were considered
to have clinical malaria. For children aged <1, a positive
cytb-PCR in conjunction with a parasite density above
10p/μl was considered positive. These cut-offs were
chosen as they have been reported to have sensitivities
and specificities of 80% to identify clinical malaria [27].
The results from these malaria analyses were not avail-
able to the clinicians at the hospital.
Statistical analysis
P-values were calculated with Fisher’s exact test and the
χ2 test for categorical data as appropriate. Student’s t-test
was used for continuous data. The sensitivity, specificity
and predictive capacities of clinical parameters to detect
bacteraemia were calculated.
Ethics
Written informed consent was obtained from the parent
or guardian and documented on the first page of the study
questionnaire. Both the informed consent and the study
procedures were approved by the National Health Ethics
Committee in Guinea-Bissau (reference number 15/
CNES/2010) and by the Regional Ethical Review Board in
Stockholm, Sweden (reference number 2011/64-31/1).
Results
General characteristics of children in the study
Clinical data and blood samples were obtained from 414
children that fulfilled the inclusion criteria. During two
weeks in July 2010, 39 consecutive children were excluded
due to lack of freezing media for conservation of bacteria.
Three further children were excluded since their isolates
were not frozen according to protocol. Hence, 372 chil-
dren were included in the analyses of which 48% (180)
were admitted to hospital. Categorized by the inclusion
criteria, 46% (172/372) had fever and tachycardia, 45%
(167/372) had only tachycardia while 9% (33/372) had
only fever. The mean age was 1.7 years and 44% (163/372)
were females. Of the children from whom we obtained a
report 2% (5/325) had been hospitalized during the month
prior to enrolment.
Bacteraemia prevalence, molecular epidemiology and
antibiotic susceptibility
Probable pathogens were isolated from the blood of 12%
(46/372) of the children (Table 1). S. aureus accountedfor 54% (26/48) of the isolates while non-typhoidal
Salmonella (NTS) accounted for 10% (5/48), S. pneumo-
niae for 8% (4/48) and Salmonella Typhi for 6% (3/48).
Two children had polymicrobial bacteraemia, one with S.
aureus and Streptococcus pyogenes, and one with S. aureus
and S. pneumoniae. Three out of five children under 60
days of age were infected with Enterobacteriaceae. Gram-
negative bacteria caused 55% (6/11) of the BSIs in children
aged <1 year, compared to 24% (9/37) in children aged 1–5
years (p = 0.07). Among hospitalized children 14% (25/180)
had bacteraemia, compared to 11% (21/192) among outpa-
tients (p = 0.40). S. aureus may be part of the skin flora and
hence it is possible that some of these findings were due to
contamination. The corresponding figure for non-Staphy
lococcal bacteraemia was 8% (14/180) in the hospitalized
group compared to 4% (8/191) of the outpatients
(p = 0.14). There was no mortality among hospitalized
children with Staphylococcal bacteremia (0/11), compared
with 14% (2/14) in children with non-Staphylococcal bac-
teraemia (p = 0.49). The two fatalities in the bacteraemia
group were diagnosed with neonatal sepsis and the isolated
pathogens were Escherichia coli and Enterobacter cloacae.
Probable contaminants were isolated in 31% (117/372)
of the samples. Prevalent contaminants were coagulase-
negative Staphylococci (n = 87), Sphingomonas (n = 4),
Bacillus (n = 4), and viridans group Streptococci (n = 3).
None out of four Acinetobacter was confirmed as Acine-
tobacter baumanii in MALDI-TOF analysis and they
were hence regarded as contaminants. To assess if de-
tection of S. aureus was associated with contaminants,
the prevalence of contaminants was evaluated among
patients with S. aureus, patients with other probable
pathogens, and patients with no growth of probable
pathogens. There was no difference in the frequency of
contaminants, 5/26 (19%), 6/20 (30%), and 106/326
(33%), respectively (p = 0.39).
The prevalence of S. aureus was similar in children ad-
mitted to hospital (7%, 13/180) and outpatients (7%, 13/
192) (p = 0.87). Frequent spa types were t084 (n = 7), t355
(n = 5), t127 (n = 2), t1476 (n = 2) and t4690 (n = 2). The
spa types t008, t024, t314, t491, t571, t760, t939 and t1458
were found in one isolate, each. In total, 38% (10/26) of the
isolates produced PVL. The four S. pneumoniae isolates
belonged to serotypes 6B (n = 2), 5 (n = 1) and 23F (n = 1).
Antibiotic resistance was uncommon among Gram-
positive isolates (Table 2). All S. aureus isolates remained
susceptible to methicillin. Both Enterococcus faecalis iso-
lates were susceptible to ampicillin and vancomycin. One
out of four S. pneumoniae isolates had a minimum inhibi-
tory concentration for penicillin of 0.5 mg/l. Among
Gram-negative isolates, two out of three K. pneumoniae
isolates produced ESBLs (one TEM and the other SHV
type). Similar to one of the two E. cloacae isolates, the
ESBL-producing K. pneumoniae isolates were resistant to
Table 1 Blood culture findings from children in Guinea-Bissau in relation to age and hospitalization
Pathogen Total (col. %) Age stratified prevalence (col. %) Hospitalized (col. %)
0-60 days >60-365 days >1-2 years >2-5 years Yes No
N = 372 N = 22 N = 79 N = 118 N = 105 N = 180 N = 191
Gram-positive 33 (9) 2 (7) 3 (4) 12 (9) 16 (13) 18 (5) 15 (4)
Staphylococcus aureus 26 (7) 2 (7) 3 (4) 10 (7) 11 (9) 13 (3) 13 (3)
Streptococcus pneumoniae 4 (1) - - - 4 (3) 4 (1) -
Streptococcus pyogenes 1 (0) - - - 1 (1) 1 (0) -
Enterococcus faecalis 2 (1) - - 2 (1) - - 2 (1)
Gram-negative 15 (4) 3 (11) 3 (4) 4 (3) 5 (4) 9 (2) 6 (2)
Klebsiella pneumoniae 3 (1) - 2 (2) - 1 (1) 2 (1) 1 (0)
Escherichia coli 2 (1) 2 (7) - - - 1 (0) 1 (0)
Salmonella typhi 3 (1) - - - 3 (2) 2 (1) 1 (0)
Non-typhoidal Salmonella 5 (1) - 1 (1) 3 (2) 1 (1) 2 (1) 3 (1)
Enterobacter cloacae 2 (1) 1 (4) - 1 (1) - 2 (1) -
Total children positive 46 (12) 5 (23) 6 (8) 16 (14) 21 (20) 27 (8) 21 (6)
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with ESBL-producing K. pneumoniae had been hospital-
ized within the last month. The Salmonella had uniformly
low minimum inhibitory concentrations to ciprofloxacin
and azithromycin, indicating susceptibility.
Predictors of bacteraemia
In analysis of all 46 children with growth of a pathogen in
their blood sample, no difference in age between children
with and without bacteraemia was observed (p = 0.54).
The bacteraemia prevalence was 10% (16/163) among fe-
males and 14% (30/209) among males (p = 0.19). FeverTable 2 Antibiotic resistance in bacteraemia isolates from chi
Species Antibiotic drug, n (%)
n (n) AMP AMC PCG CLX C
Gram-positive 33
Staphylococcus aureus 26 - - - 0 0
Streptococcus pneumoniae 4 0 - 1 (25)2 - 0
Streptococcus pyogenes 1 0 - 0 0 0
Enterococcus faecalis3 2 0 0 - - -
Gram-negative 15
Escherichia coli 2 1 (50) 0 - - 0
Klebsiella pneumoniae 3 3 (100) 2 (67) - - 2
Salmonella Typhi 3 0 0 - - 0
Non-typhoidal Salmonella 5 2 (40) 0 - - 0
Enterobacter cloacae5 2 - 2 (100) - - 1
AMP = Ampicillin, AMC = Amoxicillin-clavulanate, PCG = Penicillin G, CLX = Cloxacillin
GEN = Gentamicin, CLI = Clindamycin, SXT = Trimethoprim-sulfamethoxazole, CIP = C
1Defined as isolate tested R by EUCAST rules [21] if not otherwise stated.
2Intermediately resistant, minimum inhibitory concentration 0.5 mg/l.
3Both E. faecalis isolates were susceptible to vancomycin and linezolid.
4Intermediately resistant, inhibition zone diameters 30 and 24 mm respectively.
5Both E. cloacae isolates were susceptible to imipenem.had 54% (25/46) sensitivity to detect bacteraemia and its
positive predictive value (PPV) was only 12% (Table 3).
Nearly all bacteraemic children (96%, 44/46) had tachycar-
dia. However, the specificity of tachycardia as defined by
our inclusion criteria was only 10% and the PPV was 13%.
At higher tachycardia cut-offs, the specificity increased at
the expense of reduced sensitivity while the PPV remained
low. The other investigated clinical parameters were also
poorly predictive of bacteraemia (Table 3).
Similarly, in a subgroup analysis of the 22 non-
Staphylococcal bacteraemia cases we detected no differ-
ence in the prevalence of bacteraemia with regard to ageldren in Guinea-Bissau1
TX TET AZI ERY GEN CLI SXT CIP CHL
2 (8) - 0 0 0 0 0 0
3 (75) - 0 - 0 4 (100) - 3 (75)
0 - 0 - 0 0 - 1 (100)
- - - 0 - 2 (100)4 - 1 (50)
- - - 0 - 1 (50) 0 0
(67) - - - 2 (67) - 2 (67) 2 (67) 1 (33)
- 0 - 0 - 1 (33) 0 1 (33)
- 0 - 0 - 2 (40) 0 2 (40)
(50) - - - 1 (50) - 1 (50) 1 (50) 2 (100)
, CTX = Cefotaxime, TET = Tetracycline, AZI = Azithromycin, ERY = Erythromycin,
iprofloxacin, CHL = Chloramphenicol.
Table 3 Clinical predictors of bacteraemia in children in Guinea-Bissau with fever and/or tachycardia
Clinical parameter Factor present (n)
Missing
obs.1
Bacteraemia No bacteraemia P-value Sensitivity Specificity PPV2 NPV3
N = 46 N = 326 % % % %
Temperature
≥38° - 25 181 0.88 54 44 12 87
≥39° - 9 45 0.30 20 86 17 88
≥40° - 3 6 0.09 7 98 33 88
Tachycardia4
≥120≥ 160 - 44 295 0.25 96 10 13 94
≥130≥ 170 - 39 265 0.57 85 19 13 90
≥140≥ 180 - 23 167 0.88 50 49 12 87
Saturation5 4 3 10 0.20 7 97 23 88
Respiratory distress6 5 20 218 <0.01 44 32 8 81
Anaemia7 - 7 49 0.97 15 85 13 88
Convulsions 10 1 11 1.00 2 97 8 87
Lung crepitation - 13 130 0.13 28 60 9 86
Diarrhoea - 16 106 0.76 35 67 13 88
Reduced consciousness8 17 4 29 1.00 9 91 12 89
Vomiting - 15 97 0.69 33 70 13 88
MUAC9
<135 mm - 9 78 0.51 23 72 10 87
<125 mm - 3 35 0.60 8 87 8 87
<115 mm - 0 12 0.37 0 96 0 87
Leukocyte count 10
>11*109/L 85 20 117 0.41 54 53 15 89
>20*109/L 85 3 12 0.42 8 95 20 88
>11*109/L and/or fever 85 29 183 0.56 78 27 14 89
Malaria positive 52 4 13 0.25 10 95 24 88
1Missing observations may pertain either to the bacteraemic or the non-bacteraemic group.
2Positive predictive value.
3Negative predictive value.
4Heart rate cut-off for tachycardia in children aged <1 year and 1–5 years, respectively.
5Oxygen saturation of haemoglobin <90%.
6Respiratory rate ≥40 per minute in children aged 1–5 years and ≥60 in children aged <1.
7Conjunctival pallor reported by the attending paediatrician.
8Defined as less than alert on the AVPU scale (A = alert, V = voice, P = pain, U = unconscious).
9Mid-upper arm circumference, measured on 317 children ≥6 months of age.
10Number of leukocytes per cubic millimeter.
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(p = 0.21). There was weak evidence that fever of 39°C (p =
0.08) and a leukocyte particle concentration of ≥20 ×109/l
(p = 0.07) was more common in non-Staphylococcal bacter-
aemia while PPV was low at 11% and 20%, respectively.
We further assessed predictors of bacteraemia in the
167 non-febrile children (Table 4). All parameters had a
poor trade-off between sensitivity and specificity. Fifteen
non-febrile children had S. aureus infection, compared to
11 febrile children (p = 0.17). Also, E. faecalis (2), ESBL-
producing K. pneumoniae (2), E. coli (1), NTS (1) and S.
pneumoniae (1) were isolated from non-febrile children.Clinical management
Empirical antibiotic therapy with adequate coverage of the
isolated pathogen was prescribed to 61% (28/46) of the
children. The treatment regimen was selected individually
by the paediatrician, commonly ampicillin supplemented
with a single dose of gentamicin. Out of the bacteraemic
children, 22% (10/46) did not receive any antibiotic.
Among the 18 children that received no or inadequate
antibiotic treatment S. aureus caused 12 (67%) episodes
and S. Typhi two, while E. faecalis, NTS, E. cloacae and K.
pneumoniae caused one episode each. There was no dif-
ference in bacteraemia prevalence with regards to clinical
Table 4 Clinical predictors of bacteraemia in non-febrile children in Guinea-Bissau
Clinical parameter Factor present (n)
Missing
obs.1
Bacteraemia No bacteraemia P-value Sensitivity Specificity PPV2 NPV3
N = 21 N = 145 % % % %
Tachycardia4
≥120≥ 160 - 21 145 N/A 100 0 13 N/A
≥130≥ 170 - 17 132 0.15 81 9 11 76
≥140≥ 180 - 10 76 0.68 48 48 12 86
Saturation5 1 1 3 0.42 5 98 25 88
Respiratory distress6 2 7 91 0.01 33 36 7 79
Anaemia7 - 2 18 1.00 10 87 10 88
Convulsions 5 1 0 0.13 5 100 100 88
Lung crepitation - 6 55 0.41 29 62 10 86
Diarrhoea - 10 55 0.40 48 62 15 89
Reduced consciousness8 10 1 3 0.43 5 98 25 88
Vomiting - 7 46 0.88 33 68 13 88
MUAC9
<135 mm - 5 36 1.00 28 72 12 88
<125 mm - 2 15 1.00 11 88 12 88
<115 mm - 0 5 1.00 0 96 0 87
Leukocyte count10
>11*109/L 44 8 39 0.41 50 63 17 89
>20*109/L 44 1 5 0.58 6 95 17 87
Malaria positive 23 1 1 0.24 6 99 50 88
1Missing observations may pertain either to the bacteraemic or the non-bacteraemic group.
2Positive predictive value.
3Negative predictive value.
4Heart rate cut off for tachycardia in children aged <1 year and 1–5 years, respectively.
5Oxygen saturation of haemoglobin <90%.
6Respiratory rate ≥40 per minute in children aged 1–5 years and ≥60 in children aged <1.
7Conjunctival pallor reported by the attending paediatrician.
8AVPU scale alertness level less than “awake”.
9Mid-upper arm circumference, measured on 149 children ≥6 months of age.
10Number of leukocytes per cubic millimeter.
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similar in children with and without a clinical malaria
diagnosis (p = 0.67), malaria-diagnosed children were
less likely to receive antibiotic treatment (p = 0.002).
Only 18% (5/28) of the malaria-diagnosed children with
bacteraemia received adequate antibiotic treatment.
Malaria was diagnosed with microscopy in 13/227
(6%) children for which we obtained a slide and with
PCR in 14/311 (5%) children for which we obtained a
filter paper. In total, malaria was confirmed with either
method in 5% (17/320) of the investigated children. In
comparison, 64% (237/372) received a clinical malaria
diagnosis by the attending physician. The bacteraemia
prevalence in children with and without laboratory-
confirmed malaria was 24% (4/17) and 12% (37/303),
respectively (p = 0.25).Discussion
This is to our knowledge the first study on the prevalence
of bacteraemia in children in Guinea-Bissau. The preva-
lence of bacteraemia was 12% in this paediatric population
and malaria was over-diagnosed (found in 5% using la-
boratory tests, but in 64% using clinical criteria). As many
as 46% of the children with bacteraemia did not have fever
at presentation to the hospital and no clinical parameters
predicted bacteraemia with high sensitivity and specificity.
The prevalence of bacteraemia in previous studies from
Africa has ranged from 2% to 46% [1-4,13,14,28], however
most of these studies either did not use reproducible
enrolment criteria [14,28] or were focused on inpatients
[1,4,17]. We observed a poor sensitivity of 54% for fever to
detect bacteraemia. Excluding S. aureus bacteraemia the
sensitivity improved slightly to 68% which is comparable
Isendahl et al. BMC Infectious Diseases  (2014) 14:3859 Page 7 of 9to the 73% reported in a benchmark study by Brent et al.
where children at a Kenyan outpatient department were
blood cultured regardless of clinical presentation [2]. This
implies that studies limited to febrile children may under-
estimate bacteraemia incidence and that the clinical
threshold to perform blood cultures in children in Africa
presenting to hospitals needs to be low. Similarly to the
above mentioned study in Kenya, we found that tachy-
cardia had higher sensitivity to detect bacteraemia but
its specificity was poor [2]. In comparison, Nadjm et al.
reported a 67% sensitivity of the current WHO criteria
to detect invasive bacterial disease in a Tanzanian area
of high malaria transmission [4]. Although our record of
clinical parameters reflects the rudimentary conditions of
paediatric care in Guinea-Bissau, neither clinical examina-
tions nor prescribed treatments were harmonized with
WHO recommendations. Therefore we could not evaluate
the capacity of WHO criteria to predict bacteraemia. This
may limit the generalizability of our analyses of clinical
parameters in relation to bacteraemia. Future studies that
assess the predictive capacity of clinical parameters and
other screening tests need to assess these in relation to
current WHO guidelines. Also, the epidemiological design
needs to be carefully assessed to avoid selection bias both
with regards to pathogen detection as well as in evaluation
of screening algorithms.
More than half (54%) of the bacterial findings were S.
aureus, which predominated also in studies from Malawi
[12] and Nigeria [14,28]. Several other studies of bacter-
aemia in Africa, including a systematic review, have re-
ported S. pneumoniae [1-3] and NTS [4,13,17] as the most
prevalent species (in our study the second and third most
prevalent). In spite of similar findings in two previous stud-
ies from the region [14,28] S. aureus may be part of the
normal skin flora, and hence our finding of a high preva-
lence of S. aureus bacteraemia needs to be interpreted with
caution. To investigate the pathogenicity of the S. aureus
isolates they were subjected to spa typing. PVL-production
has been reported to impair neutrophil function [29] and is
associated with severe necrotizing pneumonia [30] and the
high prevalence of PVL-production in our study is a
concern. Furthermore, the spa type distribution closely
resembled that of clinical isolates in a study from Gabon
[31] and unlike studies from industrialized countries, types
084 and 355 (corresponding to MLST types 15 and 152)
were the most prevalent.
The contamination frequency in previous studies of
bacteremia in Africa has varied from 9-34% [1,2,8,9,
12-15,32], however some studies did not report the
prevalence of contamination [4,17,28] and there is vari-
ability with regards to what species are considered patho-
gens. Viridans group Streptococci, Citrobacter, Aeromonas,
Cryptococcus and Morganella are bacterial geni that may
be considered pathogenic [12-14] but that we regarded ascontaminants. Unlike previous studies [1,2], we used
MALDI-TOF to differentiate the often pathogenic Acine-
tobacter baumanii from low-pathogenic species. The wide
range in prevalence of both bacteremia and contamination
can thus partly be explained by differences in study design
and reporting customs. In Guinea-Bissau blood cultures
had not been routinely performed at the hospital or ana-
lyzed in the laboratory prior to our study, and the high
frequency of contaminants implies that our protocol was
not sufficient to avoid contamination. In future studies of
bacteraemia in Guinea-Bissau, thorough training of hos-
pital and laboratory staff is warranted. Also, since estab-
lished as well as several new molecular methods are used
in identifying microorganisms, epidemiological designs
such as case–control studies are needed to obtain results
on the clinical importance of microbe detection [33,34].
Previous studies of invasive bacterial isolates in Africa
have found varying prevalence of antibiotic resistance
[3,4,12,17]. In our study the overall antibiotic resistance
was low, however two out of three K. pneumoniae
produced ESBLs. We have recently reported that 33% of
408 children in Guinea-Bissau (from whom the 372
children in the present study originate) carried ESBL-
producing Enterobacteriaceae in their intestines [35] and
one of the two children with ESBL-producing K. pneu-
moniae bacteraemia in the present study was also a car-
rier. The presence of ESBLs also in bacteraemia is
worrying considering the limited access to antibiotic
drugs and the increased mortality in BSIs with ESBL-
producing species [17]. The WHO’s empirical treatment
recommendations for septicaemia is chloramphenicol
and/or benzylpenicillin [10,11]. The high prevalence of
chloramphenicol-susceptible S. aureus in our material
indicates this as an adequate treatment combination for
suspected bacteraemia in Guinea-Bissau. Of the bacter-
aemia isolates in our study, 83% (40/48) were susceptible
to at least one of these drugs.
There are limitations to our study. As discussed
above the high prevalence of S. aureus may reflect con-
tamination from the skin flora rather than infection.
Interestingly however, removing S. aureus from the
analysis did not alter our main finding that fever is an
insufficient marker of bacteraemia. Since we did not
measure CD4 counts or test for tuberculosis and other
underlying conditions, we could not evaluate the influ-
ence of these parameters on the occurrence of bacter-
aemia. The study period coincided with the rainy
season and was conducted at a national referral centre,
which may have influenced the distribution of patho-
gens. Standardized laboratory testing with automated
blood cultures and leukocyte counts would have
strengthened the internal validity of our study. Finally
we did not obtain follow-up data on outpatients, which
hampered our analyses about mortality.
Isendahl et al. BMC Infectious Diseases  (2014) 14:3859 Page 8 of 9Conclusion
In conclusion, the prevalence of paediatric bacteraemia in
this study was high irrespective of the presence of fever.
This indicates an urgent need to improve algorithms that
can identify children at risk of bloodstream infections in
Africa.
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